Study on using magnetic iron oxide nanoparticles as HIF-1α shRNA gene carrier to reverse cisplatin resistance of A549/CDDP cell lines

Progress in Biochemistry and Biophysics

Volumn 37, Issue 10, 2010, Pages 1090-1100

  Tu, Xin ^a   Min, Ling Feng ^a   Chen, Qiong ^a   Xie, Ming Xuan ^a   He, Ling Ling ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Genes transfection; HIF 1 RNA interference; Lung neoplasms; Magnetic iron oxide nanoparticles

Indexed keywords

ANIMALIA;

EID: 79951920750     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00208     Document Type: Article

References (22)

1. 2 tension. Am J Physiol, 1996, 271(4 Pt 1): C1172-C1180
2. Hyun J Y, Chun Y S, Kim T Y, et al. Hypoxia-inducible factor 1 alpha-mediated resistance to phenolic anticancer. Chemotherapy, 2004, 50(3): 119-126
3. Ren R M, Yu J M, Song X R, et al. Chin J Radiation Oncology, 2005, 14(6): 503-506
4. Mahairaki V, Xu L, Farah M H, et al. Targeted knock-down of neuronal nitric oxide synthase expression in basal forebrain with RNA interference. J Neurosci Methods, 2009, 179(2): 292-299
5. Dykxhoorn D M. RNA interference as an anticancer therapy: a patent perspective. Expert Opin Ther Pat, 2009, 19(4): 475-491
6. Beavis A D. On the inhibition of the mitochondrial inner membrane anion uniporter by cationic amphiphiles and other drugs. J Biol Chem, 1989, 264(3): 1508-1515 (Pubitemid 19050987)
7. Xin J, Yang D Z, Ji W W, et al. Preparation and characterization of fluorimetric folate-coupled chitosan nano-carrier. J Central South University (Science and Technology), 2010, 41(1): 161-165
8. Situ Z Q, Wu J Z, Liu B, et al. Cell Culture. Xi'an: World Books Publishing Company 1996: 186-187
9. Milacic V, Chen D, Ronconi L, et al. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts. Cancer Res, 2006, 66(21): 10478-10486 (Pubitemid 44799769)
10. Jiang J, Xia X B, Xu H Z, et al. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF. J Cell Physiol, 2009, 218(1): 66-74
11. Ramesh R, Saeki T, Templeton N S, et al. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol Ther, 2001, 3(3): 337-350 (Pubitemid 32514650)
12. Datiles M J, Johnson E A, Mccarty R E. Inhibition of the ATPase activity of the catalytic portion of ATP synthases by cationic amphiphiles. Biochim Biophys Acta, 2008, 1777(4): 362-368
13. Lambert G, Fattal E, Pinto-Alphandary H, et al. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as anovel colloidal carrier for the delivery of oligonucleotides. Pharm Res, 2000, 17(6): 707-714 (Pubitemid 30670637)
14. Xiang J J, Nie X M, Tang J Q, et al. Chin J Oncology, 2004, 26(2): 71-74
15. Xia S, Yu S Y, Yuan X L, et al. National Med J Chin, 2004, 84(8): 663-666
16. Wang W, Liu X, Tang C. The difference between multi-drug resistant cell line A549/Gem and its parental cell A549. Chin Ger J Clin Oncol, 2009, 8(4): 190-194
17. Kubo T, Sugita T, Shimose S, et al. Expression of hypoxia-inducible factor-1alpha and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours. J Bone Joint Surg Br, 2008, 90(3): 364-370 (Pubitemid 351428956)
18. Semenza G L Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 2003, 3(10): 721-732 (Pubitemid 37328811)
19. Anderson K, Lawson K A, Simmons-Menchaca M, et al. Alpha-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis. Exp Biol Med (Maywood), 2004, 229(11): 1169-1176 (Pubitemid 39602260)
20. Peer D, Dekel Y, Melikhov D, et al. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Cancer Res, 2004, 64(20): 7562-7569 (Pubitemid 39372101)
21. Voltairas P A, Fotiadis D I, Michalis L K. Hydrodynamics of magnetic drug targeting. J Biomech, 2002, 35(6): 813-821 (Pubitemid 34518379)
22. Weissleder R, Stark D D, Engelstad B L, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol, 1989, 152(1): 167-173 (Pubitemid 19024086)